Navana Pharmaceuticals Ltd has disclosed its unaudited earnings report for the second Quarter (October’22-Demcember’22).

On Tuesday (January 24th) The report was released at a meeting of the company’s board of directors.

As per the disclosure, (October’22-Demcember’22) its earnings per share (EPS) has been Tk 0.77 for against one year at the same time earnings per share (EPS) was Tk 0.78.

Last 6 months (July’22-Demcember’22) has been Tk 1.57 for against one year earnings per share (EPS) was Tk 1.54.

31 December 2022 it’s Net Asset Value (NAV) has been Tk 39.56

nj